## BACKGROUND. Dedifferentiation is a distinctive feature of cancer progression. Detailed histologic analysis of primary prostate carcinoma and synchronous lymph node metastases may improve our understanding of the complex process of cancer progression and metastasis. ## METHODS. The authors s
Expression of cathepsins B and S in the progression of prostate carcinoma
✍ Scribed by Pedro L. Fernández; Xavier Farré; Alfons Nadal; Eva Fernández; Nerea Peiró; Bonnie F. Sloane; Guo-Ping Shi; Harold A. Chapman; Elías Campo; Antonio Cardesa
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 352 KB
- Volume
- 95
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
p27 Kip1 is a cyclin-dependent kinase inhibitor whose down-regulation has been observed in several tumour models, including breast, colorectal, and gastric carcinomas. The purpose of this study was to assess p27 Kip1 protein expression in normal and benign prostatic epithelia as well as the possible
Murine SCC-VII squamous carcinoma cells have the capacity to penetrate reconstituted basement membranes (Matrigel) in vitro. The invasion of Matrigel layers by SCC-VII cells was significantly reduced by E-64, a specific inhibitor of lysosomal cysteine proteinases. The cathepsin-B-selective E-64 deri
## BACKGROUND. Endocrine therapy for prostate cancer aims to reduce the levels of circulating androgen or to inhibit androgen action by blocking the androgen receptor in the prostate, or both. Studies in various animal and human prostate cancer models suggested that there may be a downregulation o